Three-dimensional conformal postoperative radiotherapy in patients with parotid tumors: 10 Years' experience at the European Institute of Oncology

Tumori

Volumn 97, Issue 3, 2011, Pages 328-334

  Alterio, Daniela ^a   Jereczek Fossa, Barbara A ^a,b   Griseri, Mara ^a   D'Onofrio, Alberto ^a   Giugliano, Gioacchino ^a   Fiore, Maria R ^a   Vitolo, Viviana ^a   Fossati, Piero ^a,b   Piperno, Gaia ^a   Calabrese, Luca S ^a   Verri, Elena ^a   Chiesa, Fausto G ^a   Orecchia, Roberto ^a,b  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Adjuvant treatment; Parotid tumor; Postoperative radiotherapy; Toxicity

Indexed keywords

CARBOPLATIN; CISPLATIN; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; NAVELBINE;

ACUTE TOXICITY; ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CARCINOSARCOMA; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; LOCAL METASTASIS; LYMPH NODE METASTASIS; MALE; MUCOEPIDERMOID TUMOR; MUCOSAL DISEASE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PAROTID GLAND CANCER; PAROTID GLAND CARCINOMA; PAROTID GLAND METASTASIS; PAROTID GLAND TUMOR; POSTOPERATIVE RADIOTHERAPY; PRIMARY TUMOR; RADIATION DOSE; RADIATION INJURY; RADIOTHERAPY; RETROSPECTIVE STUDY; SKIN TOXICITY; TUMOR LOCALIZATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, MUCOEPIDERMOID; CARCINOMA, SQUAMOUS CELL; CARCINOSARCOMA; CYSTADENOCARCINOMA; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; EUROPE; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PAROTID NEOPLASMS; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 79960881889     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1700/912.10030     Document Type: Article

References (33)

1. Chandana SR, Conley BA: Salivary gland cancers: current treatments, molecular characteristics and new therapies. Expert Rev Anticancer Ther, 8: 645-652, 2008. (Pubitemid 351818358)
2. Armstrong JG, Harrison L, Sprio RH, Fass DE, Strong EW, Fuks ZY: Malignant tumors of major sarlivary gland origin: a matched pair analysis of the role of combined surgery and postoperative radiotherapy. Arch Otolaryngol Head Neck Surg, 116: 290-293, 1990. (Pubitemid 20100601)
3. Bouyon A, Hans S, Dubux C, Housset M: Postoperative treatment of malignant tumors of the parotid gland: radiotherapy, concomitant chemotherapy and radiation therapy? Cancer Radiotherapy, 11: 465-475, 2007. (Pubitemid 350236877)
4. Garden AS, El Nagger AK, Morrison WH, Callender DL, King Ang K, Peters LJ: Postoperative radiotherapy for malignant tumors of the parotid gland. Int J Radiat Oncol Biol Phys, 37: 79-85, 1997. (Pubitemid 27090137)
5. Chen AM, Granchi PJ, Garcia J, Bucci KM, Fu KK, Eisele DW: Local-regional recurrence after surgery without postoperative irradiation for carcinomas of the major salivary glands; implications for adjuvant therapy. Int J Radiat Oncol Biol Phys, 67: 982-987, 2007.
6. Terhaard CH, Lubsen H, Rasch CR, Levendag PC, Kaanders HH, Tjho-Heslinga RE, van den Ende PL, Burgale F; Dutch Head and Neck Oncology Cooperative Group: The role of radiotherapy in the treatment of malignant salivary gland tumors. Int J Radiat Oncol Biol Phys, 61: 103-111, 2005. (Pubitemid 40039111)
7. Koul R., Dubey A, Butler, Cooke AL, Abdoh A, Nason R: Prognostic factors depicting disease-specific survival in parotid gland tumors. Int J Radiat Oncol Biol Phys, 68: 714-718, 2007. (Pubitemid 46818747)
8. Jeannon JP, Calman F, Gleeson M, McGurk M, Morgan P, O'Connel M, Odell E, Simo R: Management of advanced parotid cancer. A systematic review. Eur J Surg Oncol, 35: 908-915, 2009.
9. International Commission on Radiation Units and Measurements: Prescribing, recording and reporting photon beam therapy. ICRU report 62. Bethesda, Maryland, USA, 1999.
10. Cox JD, Stets J, Pajak TF: Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys, 31: 1341-1346, 1995.
11. Selvin S: Modern applied biostatistical methods using S-PLUS. Oxford University Press, Oxford, 1998.
12. Collet D: Modelling survival data in medical research, Chapman & Hall, London, 1994.
13. Spiro RH: Salivary neoplasms: overview of a 30-year experience with 2,807 patients. Head Neck Surg, 8: 177-184, 1986.
14. North CA, Lee DJ, Piantoadosi S, Zahurak M, Johns ME: Carcinoma of the major salivary glands treated by surgery and postoperative radiotherapy. Int J Radiat Oncol Biol Phys, 18: 1319-1326, 1990. (Pubitemid 20234142)
15. Lima RA, Tavares MR, Dias FL, Kligerman J, Nascimento MF, Barbosa MM, Cernea CR, Soares JR, Santos IC, Salviano S: Clinical prognostic factors in malignant parotid gland tumors. Otolaryngol Head Neck Surg, 133: 702-708, 2005. (Pubitemid 41586057)
16. Renehan AG, Gleave EN, Slevin NJ, McGurk M: Clinicopathological and treatment related factors influencing survival in parotid cancer. Br J Cancer, 80: 1296-1300, 1999. (Pubitemid 29264095)
17. Licitra L. Marchini S, Spinazzé S, Rossi A, Rocca A, Grandi C, Molinari R: Cisplatin in advanced salivary gland carcinoma. A phase II study of 25 patients. Cancer, 68: 1874-1877, 1991.
18. Jones AS, Phillips DE, Cook JA, Helliwell TR: A randomised phase II trial of epirubicin and 5-fluorouracil versus cisplatinum in the palliation of advanced and recurrent malignant tumour of the salivary glands. Br J Cancer, 37: 112-114, 1993. (Pubitemid 23034933)
19. Rizk S, Robert A, Vandenhooft A, Airoldi M, Kornek G, Machiels JP: Activity of chemotherapy in the palliative treatment of salivary gland tumors: review of the literature. Eur Arch Otorhinolaryngol, 264: 587-594, 2007. (Pubitemid 46701651)
20. Surakanti SG, Agulnik M: Salivary gland malignancies: the role for chemotherapy andmolecular targeted agents. Sem Oncol, 35: 309-319, 2008. (Pubitemid 351787699)
21. Yaparpalvi R, Fontenla DP, Tyerech SK, Boselli LR, Beitler J: Parotid gland tumors; a comparison of postoperative radiotherapy techniques using three dimensional (3D) dose distributions and dose-volume histograms (DVHs). Int J Radiat Oncol Biol Phys; 40: 43-49, 1998. (Pubitemid 28027565)
22. Lima RA, Taveres MR, Dias F, Kligerman J, Nascimento MF, Barbosa MM, Cernea CR, Soares JR, Santos IC, Salvino S: Clinical prognostic factors in malignant parotid gland tumors. Otolaryngol Head Neck Surg, 133: 702-708, 2005. (Pubitemid 41586057)
23. Gurney TA, Eisele DW, Weinberg W, Shin E, Lee N: Adenoid cystic carcinoma of the major salivary glands treated with surgery and radiation. Laryngoscope, 115: 1278-1282, 2005. (Pubitemid 40962370)
24. Bhide S, Harrington JK Nutting CM: Otological toxicity after postoperative radiotherapy for parotid tumors. Clin Oncol (R Coll Radiol), 19: 77-82, 2007. (Pubitemid 46044072)
25. Nutting CM, Rowbottom CG, Cosgrove VP, Henk JM, Dearnaley DP, Robinson MH, Conway J, Webb S: Optimization of radiotherapy for carcinoma of the parotid gland: a comparison of conventional, three-dimensional conformal, and intensity modulated techniques. Radiother Oncol, 60: 163-172, 2001. (Pubitemid 32601969)
26. Lamers-Kuijper E, Schwarz M, Rasch C, Mijnheer B: Intensitymodulated vs. conformal radiotherapy of parotid gland tumors: potential impact on hearing loss. Med Dosim, 32: 237-245, 2007. (Pubitemid 350016877)
27. Bragg CM, Conway J, Robinson MH: The role of intensity-modulated radiotherapy in the treatment of patotid tumors. Int J Radiat Oncol Biol Phys, 52: 729-738, 2002. (Pubitemid 34158736)
28. Rowbottom CG, Notting CM, Webb S: Beam-orientation optimization of intensity modulated radiotherapy: clinical application to parotid gland tumors. Radiother Oncol, 59: 169-177, 2001. (Pubitemid 32452310)
29. Jereczek-Fossa BA, Krengli M, Orecchia R: Particle beam radiotherapy for head and neck tumors: radiobiological basis and clinical experience. Head Neck, 28: 750-760, 2006. (Pubitemid 44116900)
30. Griffin TW, Pajak TF, Laramore GE, Duncan W, Richter MP, Hendrickson FR, Maor MH: Neutron vs photon irradiation of inoperable salivary gland tumors: results of an RTOG-MRC cooperative randomized study. Int J Radiat Oncol Biol Phys, 15: 1085-1090, 1988. (Pubitemid 18265343)
31. Laramore GE, Krall JM, Griffin TW Duncan W, Richter MP, Saroja KR, Maor MH, Davis LW: Neutron versus photon irradiation for unresectable salivary gland tumors; final report of an RTOG-MRC randomized clinical trial. Int J Radiat Oncol Biol Phys, 27: 235-240, 1993. (Pubitemid 23304448)
32. Krull A, Schwarz R, Brackrock S, Engenhart-Cabillic R, Huber P, Prott FJ, Breteau N, Favre A, Lessel A, Koppe H, Auberger T: Neutron therapy in malignant salivary gland tumors: results of European centers. Recent Results Cancer Res, 150: 88-99, 1998.
33. Huber PE, Debus J, Latz D, Zierhut D, Bischof M, Wannenmacher M, Engenhart-Cabillic R: Radiotherapy for advanced adenoid cystic carcinoma: neutrons, photons or mixed beam? Radiother Oncol 59: 161-167, 2001. (Pubitemid 32452309)